Mejoralito Children

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with headache, toothache, flu, sore throat, and the common cold. Additionally, it is indicated for the temporary reduction of fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

This product is intended for use in pediatric patients, and healthcare professionals should refer to the dosage chart below to determine the appropriate dose based on the patient's weight or age. It is essential to adhere to the recommended dosing guidelines and not exceed the maximum dosage.

For administration, the tablets must be chewed or crushed completely before swallowing; they should not be swallowed whole. The recommended dosing intervals are every 4 hours as needed while symptoms persist, with a maximum of 5 doses in a 24-hour period. Treatment should not exceed 5 consecutive days unless directed by a physician.

Dosage Chart (chewable tablets):

• Under 24 lb / Under 2 years: Consult a doctor

• 24-35 lb / 2-3 years: 1 tablet

• 36-47 lb / 4-5 years: 1 ½ tablets

• 48-59 lb / 6-8 years: 2 tablets

• 60-71 lb / 9-10 years: 2 ½ tablets

• 72-95 lb / 11 years: 3 tablets

or as directed by a doctor

It is crucial to ensure that the patient does not receive more than the directed amount.

Contraindications

Use of this product is contraindicated in the following situations:

Patients should not use this product in conjunction with any other medication containing acetaminophen, whether prescription or nonprescription, due to the risk of acetaminophen overdose. If there is uncertainty regarding the presence of acetaminophen in other medications, consultation with a healthcare professional is advised.

Additionally, this product is contraindicated in individuals, particularly children, who have a known allergy to acetaminophen or any of the inactive ingredients contained in this formulation.

Exceeding the recommended dosage while using this product is also contraindicated, as it may lead to adverse effects.

Warnings and Precautions

Severe liver damage may occur in pediatric patients if acetaminophen is administered in excess of the recommended dosage. Specifically, the maximum daily amount should not exceed five doses within a 24-hour period. Additionally, caution is advised when administering this product concurrently with other medications containing acetaminophen, as this may increase the risk of liver injury.

Acetaminophen is associated with the potential for severe skin reactions. Healthcare professionals should be vigilant for symptoms such as skin reddening, blisters, or rash. Should any of these symptoms manifest, it is imperative to discontinue use immediately and seek medical assistance.

In cases of severe sore throat, particularly if it persists for more than two days or is accompanied by fever, headache, rash, nausea, or vomiting, prompt consultation with a healthcare provider is recommended.

Prior to administration, it is essential to consult a physician if the patient has a history of liver disease. Furthermore, if the patient is concurrently taking warfarin, a blood-thinning medication, consultation with a healthcare professional or pharmacist is advised to mitigate potential interactions.

In the event of an overdose, immediate medical attention is crucial. Patients or caregivers should contact a Poison Control Center or seek emergency medical help without delay, as timely intervention is vital for both adults and children, even in the absence of overt symptoms.

Healthcare providers should instruct patients to discontinue use and seek medical advice if any of the following occur: worsening pain that persists beyond five days, fever that worsens or lasts more than three days, the emergence of new symptoms, or the presence of redness or swelling, as these may indicate a serious underlying condition.

Side Effects

Severe adverse reactions associated with this product include significant liver damage, which may occur if a child exceeds five doses within a 24-hour period or if the product is used concurrently with other medications containing acetaminophen. Patients should be aware of the potential for severe skin reactions, which may manifest as skin reddening, blisters, or rash. In the event of any skin reaction, it is imperative to discontinue use and seek immediate medical assistance.

Additionally, if a sore throat is severe, persists for more than two days, or is accompanied by fever, headache, rash, nausea, or vomiting, patients should consult a healthcare professional promptly.

This product should not be used in conjunction with any other drug containing acetaminophen, whether prescription or nonprescription. Patients are advised to confirm the presence of acetaminophen in other medications with a doctor or pharmacist if uncertain. It is also contraindicated in individuals with a known allergy to acetaminophen or any inactive ingredients contained in this formulation.

Before using this product, it is recommended that patients consult a healthcare provider if the child is currently taking the anticoagulant warfarin or has a history of liver disease.

Patients should adhere strictly to the recommended dosage and should discontinue use and seek medical advice if pain worsens or persists beyond five days, if fever intensifies or lasts more than three days, if new symptoms arise, or if redness or swelling occurs, as these may indicate a serious condition.

In cases of overdose, immediate medical attention is crucial. Patients should contact a Poison Control Center or seek medical help without delay, as prompt intervention is essential for both adults and children, even in the absence of noticeable signs or symptoms.

Drug Interactions

Patients should consult a healthcare professional prior to using this medication if they are concurrently taking warfarin, a blood-thinning agent. The combination may elevate the risk of bleeding complications.

No additional drug interactions or laboratory test interactions have been identified for this medication.

Packaging & NDC

Below are the non-prescription pack sizes of Mejoralito Children (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 24 lbs (under 2 years) should consult a doctor for dosing recommendations. For children aged 2 to 3 years weighing 24-35 lbs, the recommended dose is 1 tablet. For those aged 4 to 5 years weighing 36-47 lbs, the dose increases to 1 1/2 tablets. Children aged 6 to 8 years weighing 48-59 lbs should receive 2 tablets, while those aged 9 to 10 years weighing 60-71 lbs may take 2 1/2 tablets. For children weighing 72-95 lbs at 11 years of age, the recommended dose is 3 tablets.

Healthcare professionals should be aware of several warnings associated with the use of this medication in pediatric patients. Severe liver damage may occur if a child takes more than 5 doses in 24 hours or if used concurrently with other medications containing acetaminophen. Additionally, acetaminophen may cause severe skin reactions, including skin reddening, blisters, and rash; if such reactions occur, use should be discontinued immediately, and medical assistance sought. If a sore throat is severe, persists for more than 2 days, or is accompanied by fever, headache, rash, nausea, or vomiting, a doctor should be consulted promptly. The medication should not be used in children with known allergies to acetaminophen or any inactive ingredients. Prior to use, consultation with a doctor or pharmacist is advised if the child is taking warfarin or has liver disease.

Dosage instructions emphasize that the medication should not be given more than directed, with doses to be repeated every 4 hours as needed while symptoms persist. The maximum frequency is 5 doses in 24 hours, and the medication should not be administered for more than 5 days unless directed by a healthcare professional.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The safety of acetaminophen during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a healthcare professional before use. While potential risks to the fetus are not clearly defined, caution is advised when considering the use of acetaminophen during pregnancy. There are no specific dosage modifications for pregnant individuals; therefore, it is essential to seek guidance from a healthcare professional regarding appropriate use.

Lactation

Nursing mothers should consult a doctor before using this product. There is a potential for excretion in breast milk, and the effects of acetaminophen on a nursing infant are not well studied; therefore, caution is advised. It is recommended to monitor the infant for any adverse effects if the nursing mother takes this medication.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment should consult a healthcare professional prior to using this product, particularly if they have a history of liver disease. The formulation contains acetaminophen, which is known to pose a risk of severe liver damage. It is critical to adhere to the recommended dosage guidelines; specifically, patients should not exceed 5 doses within a 24-hour period, as this represents the maximum daily amount. Additionally, caution is advised when considering the use of other medications that may also contain acetaminophen, as concurrent use could further increase the risk of liver injury. Regular monitoring of liver function may be warranted in patients with compromised liver health to ensure safety and efficacy.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay. Prompt medical attention is crucial for both adults and children, even in the absence of noticeable signs or symptoms.

Healthcare professionals should be aware that the lack of immediate symptoms does not preclude the potential for serious adverse effects. Therefore, vigilance and timely intervention are essential in managing overdose situations effectively.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No specific postmarketing experience details are provided in the text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is important to inform patients that this product should not be used in conjunction with any other medications containing acetaminophen, whether prescription or nonprescription. If patients are uncertain about the presence of acetaminophen in other medications, they should be encouraged to consult a doctor or pharmacist for clarification.

Patients should be cautioned against using this product if their child has a known allergy to acetaminophen or any of the inactive ingredients contained in the formulation. Providers should instruct patients to discontinue use and seek medical advice if the following occurs: pain worsens or persists for more than 5 days, fever worsens or lasts longer than 3 days, new symptoms develop, or if there is any redness or swelling, as these may indicate a serious condition.

Additionally, healthcare providers should emphasize the importance of adhering to the recommended dosage and advise patients to consult a doctor before use if their child has liver disease. It is also recommended that patients speak with a doctor or pharmacist prior to using this product if their child is currently taking the blood-thinning medication warfarin.

Storage and Handling

The product is supplied in tamper-evident packaging. It is imperative that the product not be used if the outer package is opened or if the blister is torn or broken.

Storage conditions require the product to be maintained at a temperature of 25°C (77°F), with permissible excursions between 15°C and 30°C (59°F and 86°F). Care should be taken to avoid high humidity during storage.

For reference, the expiration date and lot number can be found on the flap of the packaging.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Mejoralito Children, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)